SHR7390: Clinical Trials

2 trials of SHR7390, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 1, Unknown 1

Follow SHR7390: new trials by email Literature Review of SHR7390 trials Research Report on SHR7390

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors
SHR7390, SHR-1210, SHR3162 - Solid Tumor
Phase 1TerminatedJiangsu HengRui Medicine Co., Ltd.312017-07-242022-09-01
Phase I Study of SHR7390 in Patients With Advanced Solid Tumors
SHR7390 - Solid Tumor
Phase 1UnknownJiangsu HengRui Medicine Co., Ltd.602016-11-012019-01-15

Sponsors

Jiangsu HengRui Medicine Co., Ltd. (2)

Countries

China (2)

Top investigators

RuiHua Xu, MD, PhD (2)